Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sundararajan, V; Grann, VR; Jacobson, JS; Ahsan, H; Neugut, AI
   Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: A population-based study
   CANCER JOURNAL
   
   V. Sundararajan et al., "Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: A population-based study", CANCER J, 7(3), 2001, pp. 213-218
2. Antman, K; Benson, MC; Chabot, J; Cobrinik, D; Grann, VR; Jacobson, JS; Joe, AK; Katz, AE; Kelly, K; Neugut, AI; Russo, D; Tiersten, A; Weinstein, IB
   Complementary and alternative medicine: The role of the cancer center
   JOURNAL OF CLINICAL ONCOLOGY
   
   K. Antman et al., "Complementary and alternative medicine: The role of the cancer center", J CL ONCOL, 19(18), 2001, pp. 55S-60S
3. Jacobson, JS; Troxel, AB; Evans, J; Klaus, L; Vahdat, L; Kinne, D; Lo, KMS; Moore, A; Rosenman, PJ; Kaufman, EL; Neugut, AI; Grann, VR
   Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer
   JOURNAL OF CLINICAL ONCOLOGY
   
   J.S. Jacobson et al., "Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer", J CL ONCOL, 19(10), 2001, pp. 2739-2745
4. Grann, VR; Sundararajan, V; Jacobson, JS; Whang, W; Heitjan, DF; Antman, KH; Neugut, AI
   Decision analysis of tamoxifen for the prevention of invasive breast cancer
   CANCER JOURNAL
   
   V.R. Grann et al., "Decision analysis of tamoxifen for the prevention of invasive breast cancer", CANCER J, 6(3), 2000, pp. 169-178
5. Grann, VR; Jacobson, JS; Whang, W; Hershman, D; Heitjan, DF; Antman, KH; Neugut, AI
   Prevention with tamoxifen or other hormones versus prophylactic surgery inBRCA1/2-positive women: A decision analysis
   CANCER JOURNAL FROM SCIENTIFIC AMERICAN
   
   V.R. Grann et al., "Prevention with tamoxifen or other hormones versus prophylactic surgery inBRCA1/2-positive women: A decision analysis", CA J SCI AM, 6(1), 2000, pp. 13-20
6. Grann, VR; Jacobson, JS; Sundararajan, V; Albert, SM; Troxel, AB; Neugut, AI
   The quality of life associated with prophylactic treatments for women withBRCA1/2 mutations
   CANCER JOURNAL FROM SCIENTIFIC AMERICAN
   
   V.R. Grann et al., "The quality of life associated with prophylactic treatments for women withBRCA1/2 mutations", CA J SCI AM, 5(5), 1999, pp. 283-292
7. Grann, VR; Whang, W; Jacobson, JS; Heitjan, DF; Antman, KH; Neugut, AI
   Re-evaluation of benefits of BRCA1/2 testing - Reply
   JOURNAL OF CLINICAL ONCOLOGY
   
   V.R. Grann et al., "Re-evaluation of benefits of BRCA1/2 testing - Reply", J CL ONCOL, 17(6), 1999, pp. 1962-1962
8. Grann, VR; Whang, W; Jacobson, JS; Heitjan, DF; Antman, KH; Neugut, AI
   Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2
   JOURNAL OF CLINICAL ONCOLOGY
   
   V.R. Grann et al., "Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2", J CL ONCOL, 17(2), 1999, pp. 494-500
9. Grann, VR; Jacobson, JS; Neugut, AI
   Re: "The genetic passport"
   AMERICAN JOURNAL OF EPIDEMIOLOGY
   
   V.R. Grann et al., "Re: "The genetic passport"", AM J EPIDEM, 149(2), 1999, pp. 198-198
10. GRANN VR; PANAGEAS KS; ANTMAN KH; WHANG W; NEUGUT AI
    BREAST AND OVARIAN-CANCER PRONE WOMEN AND PROPHYLACTIC SURGERY TEMPTATION - IN REPLY
    Journal of clinical oncology
    
    V.R. Grann et al., "BREAST AND OVARIAN-CANCER PRONE WOMEN AND PROPHYLACTIC SURGERY TEMPTATION - IN REPLY", Journal of clinical oncology, 16(7), 1998, pp. 2575-2575
11. GRANN VR; PANAGEAS KS; WHANG W; ANTMAN KH; NEUGUT AI
    DECISION-ANALYSIS OF PROPHYLACTIC MASTECTOMY AND OOPHORECTOMY IN BRCA1-POSITIVE OR BRCA2-POSITIVE PATIENTS
    Journal of clinical oncology
    
    V.R. Grann et al., "DECISION-ANALYSIS OF PROPHYLACTIC MASTECTOMY AND OOPHORECTOMY IN BRCA1-POSITIVE OR BRCA2-POSITIVE PATIENTS", Journal of clinical oncology, 16(3), 1998, pp. 979-985
12. LO KMS; BEER M; CONKLING A; KOSONEN P; GRANN VR; ERICHSON RB; WEINSTEIN PL; DELPRETE SA; COHEN NS; XISTRIS D; BAR MH
    PACLITAXEL (TXL) PLUS CYCLOPHOSPHAMIDE (CTX) PLUS G-CSF AND ETOPOSIDE(VP) PLUS CTX PLUS G-CSF ARE SIMILAR IN THEIR ABILITY TO MOBILIZE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN PATIENTS WITH BREAST-CANCER UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC)
    Blood
    
    K.M.S. Lo et al., "PACLITAXEL (TXL) PLUS CYCLOPHOSPHAMIDE (CTX) PLUS G-CSF AND ETOPOSIDE(VP) PLUS CTX PLUS G-CSF ARE SIMILAR IN THEIR ABILITY TO MOBILIZE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN PATIENTS WITH BREAST-CANCER UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC)", Blood, 86(10), 1995, pp. 3934-3934